Novel molecular biomarkers of cancer therapy‐induced cardiotoxicity in adult population: a scoping review
Abstract Aim Cancer treatments are associated with cardiotoxic events that predispose to cardiac pathology and compromise the survival of patients, making necessary the identification of new molecular biomarkers to detect cardiotoxicity. This scoping review aims to identify the available evidence on...
Saved in:
Main Authors: | Irene Cartas‐Espinel, Marcelino Telechea‐Fernández, Carlos Manterola Delgado, Andrés Ávila Barrera, Nicolás Saavedra Cuevas, Angela L. Riffo‐Campos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13735 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of a cardio‐oncology unit on prevention of cardiovascular events in cancer patients
by: Alessandra Cuomo, et al.
Published: (2022-06-01) -
From Global Insights to National Impact: Advancing Cardio-Oncology in Iraq
by: Mustafa H. Ajlan, et al.
Published: (2024-12-01) -
Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma
by: Maki Todo, et al.
Published: (2025-02-01) -
The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity
by: Daniela Di Lisi, et al.
Published: (2022-06-01) -
Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)